The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy
Open accessAbstract
Today, dilated cardiomyopathy (DCM) represents the main cause of severe heart failure and disability in younger adults and thus is a challenge for public health.About 30% of DCM cases are genetic in origin; however, the large majority of cases are sporadic, and a viral or immune pathogenesis is suspected.Following the established postulates for pathogenesis of autoimmune diseases, here we provide direct evidence that an autoimmune attack directed against the cardiac β 1 -adrenergic receptor may play a causal role in DCM.First, we immunized inbred rats against the second extracellular β 1 -receptor loop (β 1 -EC II ; 100% sequence identity between human and rat) every month.All these rats developed first, receptorstimulating anti-β 1 -EC II Ab's and then, after 9 months, progressive severe left ventricular dilatation and dysfunction.Second, we transferred sera from anti-β 1 -EC II -positive and Ab-negative animals every month to healthy rats of the same strain.Strikingly, all anti-β 1 -EC II -transferred rats also developed a similar cardiomyopathic phenotype within a similar time frame, underlining the pathogenic potential of these receptor Ab's.As a consequence, β 1 -adrenergic receptor-targeted autoimmune DCM should now be categorized with other known receptor Ab-mediated autoimmune diseases, such as Graves disease or myasthenia gravis.Although carried out in an experimental animal model, our findings should further encourage the development of therapeutic strategies that combat harmful anti-β 1 -EC II in receptor Ab-positive DCM patients.Nonstandard abbreviations used: β1-adrenergic receptor (β1-AR); β1-AR second extracellular receptor loop (β1-ECII); body weight (BW); cAMP-dependent protein kinase (PKA); cardiac output (CO); dilated cardiomyopathy (DCM); glutathione-Stransferase (GST); human embryonal kidney (HEK); immunofluorescence microscopy (IFM); 125 I-labeled cyanopindolol ([ 125 I]-CYP); isobutylmethylxanthine (IBMX); left ventricular (LV); LV end-diastolic diameter (LVED); LV end-diastolic pressure (LVEDP); LV area (LVA); LV cavity area (LVCA); LV wall area (LVWA); peak change in LV pressure per time (interval) (dp/dtmax); velocity-time integral (VTI). Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
Underlying Causes and Long-Term Survival in Patients with Initially Unexplained Cardiomyopathy
Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., & Kasper, E. K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004133421502 · Cited by 1,723
The Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 963
Roskoski, R. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)99034-1 · Cited by 824
Defining criteria for autoimmune diseases (Witebsky's postulates revisited)
Rose, N. R., & Bona, C. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90244-f · Cited by 814
Chien, K. R., Knowlton, K. U., Zhu, G., & Chien, S. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.15.1835945 · Cited by 794
López-De León, A., & Rojkind, M. (1985) · Journal of Histochemistry & Cytochemistry · doi:10.1177/33.8.2410480 · Cited by 616
Research works printed but not linked: 5
- 10.1007/BF00877094 · doi:10.1007/bf00877094
- Magnusson, 1989, Clin. Exp. Immunol., 78, 42
- Scholz, 1994, Cardioscience., 5, 127
- Yan, 1999, Anal. Quant. Cytol. Histol., 21, 174
- 10.1016/0091-6749(84)90227-6 · doi:10.1016/0091-6749(84)90227-6
Cited by
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217
Reappraising the role of inflammation in heart failure
Adamo, L., Rocha-Resende, C., Prabhu, S. D., & Mann, D. L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0315-x · Cited by 765
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Immune mechanisms of hypertension
Drummond, G. R., Vinh, A., Guzik, T. J., & Sobey, C. G. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0160-5 · Cited by 428
Heymans, S., Hirsch, E., Anker, S. D., Aukrust, P., Balligand, J.-L., Cohen-Tervaert, J. W., Drexler, H., Filippatos, G., Felix, S. B., Gullestad, L., et al. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfn043 · Cited by 323
Metadata
- Authors
- Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G., & Lohse, M. J.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-05-15
- Volume
- 113
- Issue
- 10
- Pages
- 1419-1429
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2098892892
- Cited by
- 383
- References
- 52
- FWCI
- 14.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. https://app.cochat.ai/papers/10.1172/jci200420149
- The paper
- Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G., & Lohse, M. J. (2004). Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. Journal of Clinical Investigation. https://doi.org/10.1172/jci200420149
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.